Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
11.73
+0.05 (0.43%)
Jul 11, 2025, 3:39 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
G Protein-coupled Receptor
151.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
151.00K